← SynDRA

GLESATINIB

SynDRA canonical compound SYN0039144 — structure-anchored drug synonym record

Clinical phasePhase 2
Primary target(s)AXL | FLT1 | FLT4 | KDR | MET | MST1R | TEK
Mechanism of actiontyrosine kinase inhibitor

All known targets

Mechanisms of action (all sources)

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

Cross-references

Synonyms

Look up GLESATINIB in the interactive SynDRA portal →